Literature DB >> 4359420

In vitro polyoma DNA synthesis: characterization of a system from infected 3T3 cells.

T Hunter, B Francke.   

Abstract

A lysate from hypotonically swollen polyoma-infected BALB/3T3 cells incorporated labeled deoxynucleotide triphosphates into both viral and cellular DNAs. The incorporation was stimulated by the presence of ATP, deoxynucleotide triphosphates, thiols, and magnesium ions. Strong inhibition of incorporation was observed with thiol reagents and arabinosyl nucleotide triphosphates. The rate of in vitro synthesis increased with the temperature of incubation as expected. Incorporation into cellular DNA for up to 2 h was observed in lysates from virus-infected and serum-stimulated cells but not from resting cells. Synthesis in the system, therefore, appeared to reflect the physiological state of the cells before preparation of the lysate. Incorporation into viral DNA stopped far sooner than that into cellular DNA. During the initial phase of the in vitro incubation, incorporation occurred into viral replicative intermediates (RI). These RIs had identical properties to those isolated after in vivo pulse labeling and a substantial proportion of them was matured to form I DNA at later times in the incubation through all the stages known to occur in vivo. Density labeling of the in vitro product showed that practically all of the RIs pre-existing in the infected cell took part in the in vitro reaction. Analysis of DNA labeled in vitro in the presence of 5-bromodeoxyuridine triphosphate showed that synthesis occurred on RIs at all stages of replication and that the progeny strands were elongated by up to 80% of unit viral DNA length. Pre-existing RIs, pulse labeled in vivo, showed evidence of a pool at a late stage of replication which required elongation of their progeny strands by approximately 25% during conversion to form I molecules. From density-labeling experiments, we were also able to show that viral DNA synthesis in vitro was semiconservative. The major reason for cessation of viral DNA synthesis in vitro was the very limited ability of the lysate to initiate new rounds of viral DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4359420      PMCID: PMC355267     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Intermediate in SV40 DNA chain growth.

Authors:  G C Fareed; N P Salzman
Journal:  Nat New Biol       Date:  1972-08-30

2.  The effect of cycloheximide on DNA synthesis in cells productively-infected with polyoma virus.

Authors:  P E Branton; W P Cheevers; R Sheinin
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

3.  DNA replication in SV40 infected cells. I. Analysis of replicating SV40 DNA.

Authors:  A J Levine; H S Kang; F E Billheimer
Journal:  J Mol Biol       Date:  1970-06-14       Impact factor: 5.469

4.  Complementation and transformation by temperature-sensitive mutants of polyoma virus.

Authors:  W Eckhart
Journal:  Virology       Date:  1969-05       Impact factor: 3.616

5.  Drugs which affect the structure and function of DNA.

Authors:  M J Waring
Journal:  Nature       Date:  1968-09-28       Impact factor: 49.962

6.  Phosphate transport, nucleotide pools, and ribonucleic acid synthesis in growing and in density-inhibited 3T3 cells.

Authors:  M J Weber; G Edlin
Journal:  J Biol Chem       Date:  1971-03-25       Impact factor: 5.157

7.  A nuclear system for DNA replication from synchronized HeLa cells.

Authors:  D L Friedman; G C Mueller
Journal:  Biochim Biophys Acta       Date:  1968-07-23

8.  Synthesis of deoxyribonucleic acid by isolated liver nuclei.

Authors:  W E Lynch; R F Brown; T Umeda; S G Langreth; I Lieberman
Journal:  J Biol Chem       Date:  1970-08-10       Impact factor: 5.157

9.  Origin and direction of simian virus 40 deoxyribonucleic acid replication.

Authors:  G C Fareed; G F Garon; N P Salzman
Journal:  J Virol       Date:  1972-09       Impact factor: 5.103

10.  RNA synthesis initiates in vitro conversion of M13 DNA to its replicative form.

Authors:  W Wickner; D Brutlag; R Schekman; A Kornberg
Journal:  Proc Natl Acad Sci U S A       Date:  1972-04       Impact factor: 11.205

View more
  11 in total

1.  Viral and cellular DNA synthesis in nuclei from human lymphocytes transformed by Epstein-Barr virus.

Authors:  W C Benz; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

2.  In vitro polyoma DNA synthesis: requirement for cytoplasmic factors.

Authors:  B Francke; T Hunter
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

3.  DNA polymerases in polyoma virus-infected mouse kidney cells.

Authors:  U Wintersberger; E Wintersberger
Journal:  J Virol       Date:  1975-11       Impact factor: 5.103

4.  In vitro polyoma DNA synthesis: inhibition by 1-beta-d-arabinofuranosyl CTP.

Authors:  T Hunter; B Francke
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

5.  A cell-free assay measuring repair DNA synthesis in human fibroblasts.

Authors:  G Ciarrocchi; S Linn
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

6.  In vitro polyoma DNA synthesis: studies on an early temperature-sensitive mutant.

Authors:  B Francke; T Hunter
Journal:  J Virol       Date:  1974-01       Impact factor: 5.103

7.  Discontinuous synthesis of both strands at the growing fork during polyoma DNA replication in vitro.

Authors:  M Närkhammar-Meuth; R Eliasson; G Magnusson
Journal:  J Virol       Date:  1981-07       Impact factor: 5.103

8.  An oligoribonucleotide polymerase from SV40-infected cells with properties of a primase.

Authors:  G Kaufmann; H H Falk
Journal:  Nucleic Acids Res       Date:  1982-04-10       Impact factor: 16.971

9.  Most short DNA molecules isolated from 3T3 cells are not nascent.

Authors:  J Kowalski; D T Denhardt
Journal:  Nucleic Acids Res       Date:  1978-11       Impact factor: 16.971

10.  Simian virus 40 DNA replication in nuclear monolayers.

Authors:  D J Le Blanc; M F Singer
Journal:  J Virol       Date:  1976-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.